Lai H Henry, Boone Timothy B, Yang Guang, Smith Christopher P, Kiss Susanna, Thompson Timothy C, Somogyi George T
Neurourology Laboratory, Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
Neurochem Int. 2004 Dec;45(8):1185-93. doi: 10.1016/j.neuint.2004.06.016.
Caveolin-1 (Cav1), a structural protein of caveolae, plays cell- and context-dependent roles in signal transduction pathway regulation. We have generated a knockout mouse homozygous for a null mutation of the Cav1 gene. Cav1 knockout mice exhibited impaired urinary bladder contractions in vivo during cystometry. Contractions of male bladder strips were evoked with electric and pharmacologic stimulation (5-40 Hz, 1-10 microM carbachol, 10 mM alpha,beta-methylene ATP, 100 mM KCl). Acetylcholine (ACh) and norepinephrine (NE) release from bladder strips were measured with a radiochemical method by incubating the strips with 14C-choline and 3H-NE prior to electric stimulation, whereas ATP release was measured using the luciferin-luciferase assay with a luminometer. A 60-75% decline in contractility was observed when Cav1 knockout muscle strips were stimulated with electric current or carbachol, compared to wildtype muscle strips. No difference in contractility was noted when contractions were evoked either by the purinergic agonist alpha,beta-methylene ATP, or by extracellular potassium. To investigate the relative contribution of non-cholinergic activity to bladder contractility, the amplitude of the electric stimulation-evoked contractions was compared in the presence of the muscarinic antagonist atropine (1 microM). While the non-muscarinic (purinergic) response was unaltered, muscarinic cholinergic response was principally disrupted in Cav1 knockout mice. The loss of Cav1 gene expression was also associated with a 70% reduction in ACh release. NE and ATP release was not altered. It is concluded that the loss of caveolin-1 is associated with disruption of M3 muscarinic cholinergic activity in the bladder. Both pre-junctional (acetylcholine neurotransmitter release from neuromuscular junctions) and post-junctional (M3 receptor-mediated signal transduction in bladder smooth muscles) mechanisms are disrupted, resulting in impaired bladder contraction.
小窝蛋白-1(Cav1)是小窝的一种结构蛋白,在信号转导通路调节中发挥细胞和环境依赖性作用。我们构建了Cav1基因纯合无效突变的基因敲除小鼠。在膀胱内压测量过程中,Cav1基因敲除小鼠在体内表现出膀胱收缩受损。通过电刺激和药理学刺激(5-40Hz,1-10μM卡巴胆碱、10mMα,β-亚甲基ATP、100mM氯化钾)诱发雄性膀胱条收缩。在电刺激前,通过将膀胱条与14C-胆碱和3H-去甲肾上腺素孵育,采用放射化学方法测量膀胱条中乙酰胆碱(ACh)和去甲肾上腺素(NE)的释放,而ATP释放则使用发光计通过荧光素-荧光素酶测定法进行测量。与野生型肌肉条相比,当用电流或卡巴胆碱刺激Cav1基因敲除肌肉条时,观察到收缩力下降60-75%。当由嘌呤能激动剂α,β-亚甲基ATP或细胞外钾诱发收缩时,收缩力没有差异。为了研究非胆碱能活性对膀胱收缩力的相对贡献,在毒蕈碱拮抗剂阿托品(1μM)存在的情况下,比较电刺激诱发收缩的幅度。虽然非毒蕈碱(嘌呤能)反应未改变,但毒蕈碱胆碱能反应在Cav1基因敲除小鼠中主要受到破坏。Cav1基因表达的缺失还与ACh释放减少70%有关。NE和ATP释放未改变。结论是小窝蛋白-1的缺失与膀胱中M3毒蕈碱胆碱能活性的破坏有关。节前(神经肌肉接头处乙酰胆碱神经递质释放)和节后(膀胱平滑肌中M3受体介导的信号转导)机制均受到破坏,导致膀胱收缩受损。